But the team found that the purified EPS, contrary to long-held belief, isn't really sticky to the cells at all. Rather, they found, it repels those cells that do not produce EPS. They found that ...

Shares of Brainstorm Cell were trading at $1.35 as of March 26. Over the last 52-week period, shares are down 88.74%. Given that these returns are generally negative, long-term shareholders are likely ...

Reports FY24 revenue $32M vs $31.3M last year. David Portnoy, Cryo-Cell’s (CCEL) Chairman of the Board and Co-CEO remarked, “The Company’s 2024 fiscal results were impacted by continued ...

Investment analysts at Zacks Research lowered their Q1 2025 earnings estimates for shares of First Solar in a note issued to ...

Cryo-Cell International reported earnings per share of 7 cents. This was above the analyst estimate for EPS of -2 cents. The company reported revenue of $7.85 million. This was 1.01% worse than ...

HC Wainwright also issued estimates for MiNK Therapeutics’ Q2 2025 earnings at ($0.35) EPS, Q3 2025 earnings at ... invariant natural killer T (iNKT) cell therapies to treat cancer and other ...